- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 50/02 - Quinones à structure quinoïde monocyclique
Détention brevets de la classe C07C 50/02
Brevets de cette classe: 50
Historique des publications depuis 10 ans
|
1
|
3
|
4
|
1
|
2
|
3
|
2
|
3
|
2
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| PTC Therapeutics, Inc. | 475 |
7 |
| DSM IP Assets B.V. | 5373 |
6 |
| BASF SE | 21308 |
4 |
| Centre National de La Recherche Scientifique | 11026 |
2 |
| Institut National des Sciences Appliquees de Lyon | 310 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3003 |
2 |
| Universite Claude Bernard Lyon 1 | 1082 |
2 |
| Zhejiang Nhu Company Limited | 194 |
2 |
| Zhejiang University | 3448 |
2 |
| Zhejiang Nhu Pharmaceutical Co., Ltd. | 16 |
2 |
| Aoyama Gakuin Educational Foundation | 4 |
1 |
| Apex Therapeutics, Inc. | 2 |
1 |
| Bangor University | 43 |
1 |
| Florida Atlantic University Board of Trustees | 110 |
1 |
| Fudan University | 767 |
1 |
| Georgetown University | 628 |
1 |
| Indiana University Research and Technology Corporation | 783 |
1 |
| Korea Atomic Energy Research Institute | 463 |
1 |
| Nalco Company | 535 |
1 |
| The Ritsumeikan Trust | 178 |
1 |
| Autres propriétaires | 9 |